Patents help protect the significant investments tied to the development of new drugs and should never be abused to prevent the market entry of legitimate competitors, Edward C. Lawrence writes. Efforts to impede the pathway to biosimilar approval are a brake on innovation and will hurt consumers, Lawrence writes.

Full Story:
RxObserver blog

Related Summaries